SBRI: Medicines and dementia - phase 1

Apply for a share of up to £240,000 to develop disruptive, innovative solutions supporting people at risk of dementia to manage their medications

The Scottish Health Industry Partnership is funding a Small Business Research Initiative (SBRI) competition to support the development of disruptive healthcare innovations.

These innovations would focus on medicines and developing new tools for use in clinical practice supporting people at risk of dementia to manage their medications. The aim is mid-life management for people aged 40 to 55, with risk-factors or early signs of dementia.

Your project can focus on one or more of the following:

• identification of people utilising clinical risk factors for example cardiovascular risk factors, family history, diabetes or hypertension
• adherence to medicines for conditions identified as being linked to development of dementia such as delirium, confusion and other risk factors

Your project must work with local, regional and national NHS Boards, Social Care Services Regional Test Beds and Primary Care groups where appropriate. You must aim to provide solutions which are readily tested, evaluated and reported in order to affect wider national strategies and NHS adoption.

This is phase 1 of a potential 2 phase competition. Phase 1 will focus on technical feasibility studies. Only the successful applicants from phase 1 will potentially be invited to apply to take part in phase 2 to continue with prototype development and evaluation.

Find out more about this medicines and dementia SBRI.

Potential applicants can register to secure a place at the virtual SBRI briefing session on Friday 10 March 2023, to learn more about the competition, processes and funding.

First published 28 February 2023